期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
New pyrometallurgical process of EAF dust treatment with CaO addition 被引量:8
1
作者 Romchat Chairaksa-Fujimoto yosuke inoue +2 位作者 Naoyoshi Umeda Satoshi Itoh Tetsuya Nagasaka 《International Journal of Minerals,Metallurgy and Materials》 SCIE EI CAS CSCD 2015年第8期788-797,共10页
The non-carbothermic zinc pyrometallurgical processing of electric arc furnace(EAF) dust was investigated on a laboratory scale. The main objective of this process was to convert highly stable zinc ferrite(Zn Fe2O4), ... The non-carbothermic zinc pyrometallurgical processing of electric arc furnace(EAF) dust was investigated on a laboratory scale. The main objective of this process was to convert highly stable zinc ferrite(Zn Fe2O4), which accounts for more than half of total zinc in the EAF dust, into Zn O and Ca2Fe2O5 by Ca O addition. The EAF dust was mixed with Ca O powder in various ratios, pressed into pellets, and heated in a muffle furnace in air at temperatures ranging from 700 to 1100°C for a predetermined holding time. All Zn Fe2O4 was transformed into Zn O and Ca2Fe2O5 at a minimum temperature of 900°C within 1 h when sufficient Ca O to achieve a Ca/Fe molar ratio of 1.1 was added. However, at higher temperatures, excess Ca O beyond the stoichiometric ratio was required because it was consumed by reactions leading to the formation of compounds other than Zn Fe2O4. The evaporation of halides and heavy metals in the EAF dust was also studied. These components could be preferentially volatilized into the gas phase at 1100°C when Ca O was added. 展开更多
关键词 electric arc furnace dust PYROMETALLURGY zinc oxid
下载PDF
Neoadjuvant therapy for resectable pancreatic cancers
2
作者 yosuke inoue Hiromichi Ito Yu Takahashi 《Hepatobiliary Surgery and Nutrition》 SCIE 2022年第4期583-585,共3页
Pancreatic cancer(PC)is a potentially systemic disease with more diverse biology than generally considered.At present,surgical resection is the only curative therapy available for patients with PC,and its indications ... Pancreatic cancer(PC)is a potentially systemic disease with more diverse biology than generally considered.At present,surgical resection is the only curative therapy available for patients with PC,and its indications have long been discussed based on anatomical resectability.A recent consensus recommends neoadjuvant therapy(NAT)for anatomically borderline resectable(BR)cancers(1)as well as induction therapy for unresectable locally advanced(UR-LA)or metastatic(UR-M)cancers. 展开更多
关键词 CANCERS THERAPY CURATIVE
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部